MMP9 and neoplasm: As shown in Fig. 3c and d, the immunostaining of PCNA and MMP-9 proteins in the tumor xenografts established by SLC6A1 expression vector-transfected PC3 or LNCaP cells were markedly stronger than that in the control groups (both P < 0.05).